154 related articles for article (PubMed ID: 22005870)
1. Reduced expression of von Hippel-Lindau protein correlates with decreased apoptosis and high chondrosarcoma grade.
Chen C; Zhou H; Liu X; Liu Z; Ma Q
J Bone Joint Surg Am; 2011 Oct; 93(19):1833-40. PubMed ID: 22005870
[TBL] [Abstract][Full Text] [Related]
2. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
3. Clear cell chondrosarcoma in Von Hippel-Lindau disease.
Dreijerink KMA; van Leeuwaarde RS; Hackeng WM; Giles RH; de Leng WWJ; Jutte PC; Suurmeijer AJH; van Nesselrooij BPM; Brosens LAA
Fam Cancer; 2020 Jan; 19(1):41-45. PubMed ID: 31673890
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.
Chen C; Zhou H; Wei F; Jiang L; Liu X; Liu Z; Ma Q
J Orthop Res; 2011 Jan; 29(1):143-51. PubMed ID: 20661931
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML
Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810
[TBL] [Abstract][Full Text] [Related]
6. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
[TBL] [Abstract][Full Text] [Related]
8. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
[TBL] [Abstract][Full Text] [Related]
9. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage.
Roe JS; Kim HR; Hwang IY; Cho EJ; Youn HD
Oncogene; 2011 Jul; 30(28):3127-38. PubMed ID: 21358672
[TBL] [Abstract][Full Text] [Related]
11. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of A disintegrin and metalloproteinase 28 is correlated with high histologic grade in conventional chondrosarcoma.
Matsuura S; Oda Y; Matono H; Izumi T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2010 Mar; 41(3):343-51. PubMed ID: 19896699
[TBL] [Abstract][Full Text] [Related]
13. The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas.
He L; Yang Z; Li Z
Pathol Res Pract; 2016 Jul; 212(7):636-42. PubMed ID: 27155928
[TBL] [Abstract][Full Text] [Related]
14. Expression of von Hippel-Lindau tumor suppressor protein (pVHL) characteristic of tongue cancer and proliferative lesions in tongue epithelium.
Hasegawa H; Kusumi Y; Asakawa T; Maeda M; Oinuma T; Furusaka T; Oshima T; Esumi M
BMC Cancer; 2017 May; 17(1):381. PubMed ID: 28549422
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
16. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis.
Nakagawa SA; Lopes A; Lopes de Carvalho A; Rossi BM; Werneck da Cunha I; Soares FA; Chung WT; Alves LA
J Bone Joint Surg Am; 2010 Jul; 92(8):1738-46. PubMed ID: 20660237
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.
Perier A; Fregni G; Wittnebel S; Gad S; Allard M; Gervois N; Escudier B; Azzarone B; Caignard A
Oncogene; 2011 Jun; 30(23):2622-32. PubMed ID: 21258414
[TBL] [Abstract][Full Text] [Related]
19. von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation.
Turcotte S; Desrosiers RR; Brand G; Béliveau R
Int J Cancer; 2004 Dec; 112(5):777-86. PubMed ID: 15386385
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of HIF-1α overexpression in germ cell tumors of the testis.
Vranic S; Hes O; Grossmann P; Gatalica Z
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):165-9. PubMed ID: 22820662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
